Advisornet Financial’s iShares US Pharmaceuticals ETF IHE Stock Holding History

Advisornet Financial’s Portfolio IHE Stock Details IHE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$48.8K	Sell	493 -40,500	-99%	-$3.65M	﹤0.01%	1121
2026 Q1	$3.55M	Buy	40,993 +983	+2%	+$86K	0.18%	108
2025 Q4	$3.39M	Buy	+40,010	New	+$3.19M	0.18%	106
2023 Q2	–	Sell	-111	Closed	-$6.49K	–	2422
2023 Q1	$6.49K	Hold	111	–	–	﹤0.01%	1421
2022 Q4	$6.89K	Buy	+111	New	+$6.68K	﹤0.01%	1390

Other funds holding IHE

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

TD Asset Management Toronto, Ontario, Canada $115B AUM 41.58% 1-Year Est. Return

Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 57.61% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

IWS

Insight Wealth Strategies San Ramon, California $1.02B AUM 38% 1-Year Est. Return

Advisornet Financial's IHE Position: Q2 2026 in Review

Advisornet Financial reduced its iShares US Pharmaceuticals ETF (IHE) stake by 99% in Q2 2026, selling an estimated $3.65M and leaving 493 shares worth $48.8K. The position accounts for ﹤0.01% of the portfolio, ranked #1121.

Advisornet Financial first reported a position in IHE in Q4 2022 and has held it in 5 quarters since. The position peaked at $3.55M in Q1 2026. 209 funds tracked by Wall St. Rank hold IHE as of Q2 2026.

Advisornet Financial held 493 shares of iShares US Pharmaceuticals ETF worth $48.8K as of Q2 2026.
Advisornet Financial sold 40,500 iShares US Pharmaceuticals ETF shares in Q2 2026, an estimated $3.65M.
iShares US Pharmaceuticals ETF made up ﹤0.01% of Advisornet Financial's portfolio in Q2 2026, its #1121 holding.
Advisornet Financial first reported a position in iShares US Pharmaceuticals ETF in Q4 2022 and has held it in 5 quarters since.
Advisornet Financial's iShares US Pharmaceuticals ETF position peaked at $3.55M in Q1 2026.
209 funds tracked by Wall St. Rank held iShares US Pharmaceuticals ETF as of Q2 2026.

Based on Advisornet Financial's 13F filing for Q2 2026, filed 23 Jul 2026.